Add like
Add dislike
Add to saved papers

Sex difference in the survival rate of wild brushtail possums (Trichosurus vulpecula) experimentally challenged with bovine tuberculosis.

The main wildlife reservoir of bovine tuberculosis (TB) in New Zealand is the introduced brushtail possum (Trichosurus vulpecula), with spillover of infection from possums to livestock being regarded as the largest barrier to eradicating TB from the country. Past studies have experimentally challenged possums with Mycobacterium bovis (the causative agent of TB) to quantify infection parameters. However, the challenge models used are invariably non-representative of natural infection due to their resulting in much faster rates, and different clinical patterns of disease progression. We monitored the survival of 16 wild free-living possums, fitted with VHF mortality collars and experimentally challenged with a new model, out to six months post-challenge. The aim was to assess whether the new model does indeed result in an ongoing pathogenesis trajectory that is more reflective of natural TB in possums. The mean survival period of challenged possums (~4.6months) did not differ from that estimated for wild free-living possums with naturally acquired TB. In addition, and unexpectedly, infected males survived on average for five weeks longer than females. This significant difference has not been previously observed in experimental trials with other TB/possum challenge models. If this is reflective of natural disease (as is the survival period produced by the percutaneous challenge model), TB infected males in the wild may be generating more secondary cases of infection than infected females. This insight has important implications for understanding the dynamics of, and managing, the disease in its New Zealand wildlife reservoir.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app